Recruited to injury sites by chemotactic factors where they differentiate based on local signals
Description 100mg [3mL] Read the GHK-Cu research overview Frequently Asked Questions What is GHK-Cu
Understanding these mechanisms explains why certain peptides show such compelling neuropathy research and why a multi-peptide approach often makes more sense than targeting a single pathway
Your provider can help identify which pattern aligns with your circadian rhythm and baseline digestive function
Experimental evidence shows that GHK-Cu modulates the expression of thousands of genes involved in tissue remodeling, inflammatory response, and oxidative stress mitigation (Pickart and Margolina 2018
Expected timeline: Days 1-3: Continued acute symptoms, peptide beginning to accumulate Days 4-7: Inflammation reduction often noticeable, pain decreasing Week 2-3: Significant improvement in most acute strains Week 4-6: Return to normal function, consider tapering Complementary approaches: Gentle movement, avoiding complete rest